Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Solid Biosciences (SLDB)
NASDAQ:SLDB
Solid Biosciences (SLDB) Stock Price & Analysis
425 Followers
SLDB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.40 - $14.26
Previous Close$6.14
Volume17.71K
Average Volume (3M)34.26K
Market Cap
$120.75M
Enterprise Value-$39.38M
Total Cash (Recent Filing)$185.51M
Total Debt (Recent Filing)$25.77M
Price to Earnings (P/E)-0.7
Beta1.34
Next Earnings
Aug 11, 2023EPS Estimate
-$1.64Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-8.36
Shares Outstanding19,601,539
10 Day Avg. Volume11,132
30 Day Avg. Volume34,258
Standard Deviation0.31
R-Squared0.06
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)232.79
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-5.89
Enterprise Value/Gross Profit-4.87
Enterprise Value/Ebitda0.36
Forecast
1Y Price Target
$7.00Price Target Upside13.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Solid Biosciences News
Pre-EarningsIs SLDB a Buy, Before Earnings?
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SLDB FAQ
What was Solid Biosciences’s price range in the past 12 months?
Solid Biosciences lowest stock price was $3.40 and its highest was $14.26 in the past 12 months.
What is Solid Biosciences’s market cap?
Currently, no data Available
When is Solid Biosciences’s upcoming earnings report date?
Solid Biosciences’s upcoming earnings report date is Aug 11, 2023 which is in 71 days.
How were Solid Biosciences’s earnings last quarter?
Solid Biosciences released its earnings results on May 11, 2023. The company reported -$1.54 earnings per share for the quarter, beating the consensus estimate of -$1.612 by $0.072.
Is Solid Biosciences overvalued?
According to Wall Street analysts Solid Biosciences’s price is currently Undervalued.
Does Solid Biosciences pay dividends?
Solid Biosciences does not currently pay dividends.
What is Solid Biosciences’s EPS estimate?
Solid Biosciences’s EPS estimate is -$1.64.
How many shares outstanding does Solid Biosciences have?
Solid Biosciences has 19,601,540 shares outstanding.
What happened to Solid Biosciences’s price movement after its last earnings report?
Solid Biosciences reported an EPS of -$1.54 in its last earnings report, beating expectations of -$1.612. Following the earnings report the stock price went up 3.871%.
Which hedge fund is a major shareholder of Solid Biosciences?
Among the largest hedge funds holding Solid Biosciences’s share is Perceptive Advisors LLC. It holds Solid Biosciences’s shares valued at 17M.
---
Solid Biosciences Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-30.55%
12-Months-Change
Fundamentals
Return on Equity
-49.13%
Trailing 12-Months
Asset Growth
10.61%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Solid Biosciences
Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy. It develops gene therapies, disease modifying therapies, and assistive devices for the cure of DMD. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Arnold, Annie Ganot and Gilad David Hayeem in March 2013 and is headquartered in Cambridge, MA.
---
Top 5 ETFs holding SLDB
iShares Core S&P Total U.S. Stock Market ETF
$26.55K
Up to five ETFs with an Outperform Smart Score that hold SLDB. The ETFs are listed according to market value of SLDB within the ETF
---
---